Link To NPR’s “I Got A ‘Mild’ Breakthrough Case. Here’s What I Wish I’d Known”, With Links To Additional Resources On Testing And Treatment

In this post I link to NPR’s outstanding article, “I Got A ‘Mild’ Breakthrough Case. Here’s What I Wish I’d Known“, September 12, 2021.

The above article is an outstanding review of what is known about breakthrough COVID infections as of now. I recommend reviewing the entire article.

Even if you’ve been fully vaccinated against COVID-19, you need to be tested if you have been exposed to someone with COVID-19 or you have symptoms that could be due to COVID-19. See COVID-19 Testing Overview from the CDC.
Updated Aug. 2, 2021

Also be sure to review MONOCLONAL ANTIBODIES FOR HIGH-RISK COVID-19 POSITIVE PATIENTS from the combatcovid.hhs.gov website.

Please review HOW DO I KNOW IF I’M HIGH RISK, AND WHAT DO I DO NEXT?

Contact the Combat COVID Monoclonal Antibodies Call Center: 1-877-332-6585

The information on this page can help you decide if you or a loved one may qualify for monoclonal antibody (mAb) treatment and, if you do qualify, how you can get mAb treatment.

People aged 12 or older may be considered at high risk for developing more serious symptoms—making them eligible for mAb treatment—depending on their health history and how long they’ve had symptoms of COVID-19.

DID YOU KNOW…?

You or your loved one may be eligible for mAb treatment if you meet the following criteria:

  • Are an adult or pediatric (≥ 12 years of age and weighing at least ≥ 40 kg) patient
  • Have tested positive for COVID-19
  • Are experiencing mild or moderate symptoms of COVID-19
  • Experienced your first symptoms of COVID-19 in the last 10 days
  • Are at high risk for having more serious symptoms of COVID-19 and/or going into the hospital

People can be at high risk because of many reasons including their age, having an underlying medical condition, and other things. Some of the most common reasons are listed below:

  • Age ≥ 65 years
  • Obesity or being overweight based on Centers for Disease Control and Prevention clinical growth charts
  • Pregnancy
  • Chronic kidney disease
  • Diabetes
  • Immunosuppressive disease or immunosuppressive treatment
  • Heart or circulatory conditions such as heart failure, coronary artery disease, cardiomyopathies, and possibly high blood pressure (hypertension)
  • Chronic lung diseases including COPD (chronic obstructive pulmonary disease), asthma (moderate to severe), interstitial lung disease, cystic fibrosis, and pulmonary hypertension
  • Sickle cell disease
  • Neurodevelopmental disorders such as cerebral palsy
  • Having a medical device (for example, tracheostomy, gastrostomy, or positive pressure ventilation [not related to COVID-19])

Clinicians, please review the combatcovid.hhs.gov website resource, MONOCLONAL ANTIBODY RESOURCES FOR CLINICIANS.

HEALTHCARE PROFESSIONAL RESOURCES

PATIENT RESOURCES

FOOD AND DRUG ADMINISTRATION (FDA) EUA RESOURCES

 

This entry was posted in Centers For Disease Control And Prevention, COVID-19, COVID-19 Treatment, Health And Human Services, Infectious Diseases. Bookmark the permalink.